Evinz Drugs Private Limited
Produces and sells pharmaceutical products, drugs, and medicines.
2002 | Hyderabad, Telangana (India) | Active
Evinz Drugs Profile
Key Indicators
- Authorised Capital ₹ 6.00 M
- Paid Up Capital ₹ 4.14 M
- Company Age 22 Year, 2 Months
- Last Filing with ROC 31 Mar 2020
- Open Charges ₹ 1.30 Cr
- Revenue Growth 4.57%
- Profit Growth -11.43%
- Ebitda 33.72%
- Net Worth 15.21%
- Total Assets -29.33%
About Evinz Drugs
Evinz Drugs Private Limited (EDPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 09 December 2002 and has a history of 22 years and two months. Its registered office is in Hyderabad, Telangana, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2020. It's a company limited by shares with an authorized capital of Rs 6.00 M and a paid-up capital of Rs 4.14 M.
The company currently has active open charges totaling ₹1.30 Cr.
Chapalamadugu Nitin and Eswar Magham serve as directors at the Company.
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24230TG2002PTC040059
- Company No.
040059
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
09 Dec 2002
- Date of AGM
29 Dec 2020
- Date of Balance Sheet
31 Mar 2020
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Pharma
Who are the key members and board of directors at Evinz Drugs?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Eswar Magham  | Additional Director | 03-Apr-2017 | Current |
| Chapalamadugu Nitin | Director | 04-Oct-2016 | Current |
Financial Performance of Evinz Drugs.
Evinz Drugs Private Limited, for the financial year ended 2020, experienced modest growth in revenue, with a 4.57% increase. The company also saw a substantial fall in profitability, with a 11.43% decrease in profit. The company's net worth Soared by an impressive increase of 15.21%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Evinz Drugs?
In 2020, Evinz Drugs had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Clark Lloyd Designers Private LimitedEswar Magham is a mutual person
- Superspan Infratech Private Limited
Eswar Magham is a mutual person
- Brill Foods India Private Limited
Eswar Magham is a mutual person
Charges (Loans)
Open Charges
₹13.00 M
Satisfied Charges
₹0
Charges Breakdown by Lending Institutions
- Others : 1.00 Cr
- Andhra Bank : 0.30 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 09 Aug 2016 | Others | ₹1.00 Cr | Open |
| 16 May 2006 | Andhra Bank | ₹3.00 M | Open |
How Many Employees Work at Evinz Drugs?
Evinz Drugs has a workforce of 0 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Evinz Drugs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Evinz Drugs's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
